External Advisory Committee

Chairman

David McLoughlin, PHD, MBA

Vice President,
Adaptive Biotechnologies

Industry Association / Economic Development Organization

Lucie Rochard, PhD

Liaison for Scientific & Entrepreneurial Initiatives,
MassBio

Christine Dixon Thiesing, MBA

Director of Academic Programs,
South Carolina Research Authority

Big Pharma

Gaylene Anderson, MBA

US Director,
Contracts and Alliance Management,
Boehringer Ingelheim Pharmaceuticals

Intellectual Property Expert

Angela J. Grayson, CIPP/US, CLP

Principal Member and Founder Precipice IP PLLC

Small Business / Startup /Serial Entrepreneur

Sachin Mamidwar, MS

Co-Founder and General Manager
Orthogen, LLC

William Rosellini, JD

CEO, Nexeon MedSystems

Elaine Hamm, PHD

CEO, Ascend BioVentures COO, Kirrhos Pharmaceuticals

Shobha Parthasarathi, PHD

Vice President, External Innovation and New Ventures, Xontogeny

Investors

Matt Harbaugh, JD, MBA

Managing Director, Mountain State Capital Seed Fund

DJ Nag, PhD, MBA

Chief Investment Officer, Ventech Solutions

Juliana Garaizar, MBA

VC, Portfolia Lead Investor,
Angel Capital Association Director, Kauffman Fellow

Large Medical Device Company

Jiunn Teo, PhD

Senior Manager,
Global Research and Development,
Fresenius Medical Care

Academic Tech Transfer

Pete Donnelly, MS, MBA

Associate Vice President for Technology Partnerships and Managing Director,
Accelerate NY Seed Fund,
Stony Brook University

Manu Nair, LL.M, MBA, LL.B

Vice Chair,
High Value Opportunities Corporate Development,
Mayo Clinic

Ex-Officio

Bob Saunders

Chairman, XLH

Eugene Krentsel, PHD

Chief Scientific Officer and VP, Strategic Partnerships & Alliances, XLH